Patents by Inventor Ariel Pribluda

Ariel Pribluda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9623109
    Abstract: A method of killing a cell having a mutation in an Adenomatous polyposis coli (APC) gene is disclosed. The method comprises contacting the cell with an inhibitor of Casein kinase I (CKI), the CKI being selected from the group consisting of CKI-alpha and CKI-delta and CKI-epsilon, thereby killing the cell. The method may be used for treating cancers. Pharmaceutical compositions for treatment of cancers are also disclosed.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: April 18, 2017
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Yinon Ben-Neriah, Ela Elyada, Ariel Pribluda
  • Publication number: 20110076282
    Abstract: A method of killing a cell having a mutation in an Adenomatous polyposis coli (APC) gene is disclosed. The method comprises contacting the cell with an inhibitor of Casein kinase I (CKI), the CKI being selected from the group consisting of CKI-alpha and CKI-delta and CKI-epsilon, thereby killing the cell. The method may be used for treating cancers. Pharmaceutical compositions for treatment of cancers are also disclosed.
    Type: Application
    Filed: May 26, 2009
    Publication date: March 31, 2011
    Applicant: Yissum Research Development Company of the Hebrew Univeristy of Jerusalem Ltd
    Inventors: Yinon Ben-Neriah, Ela Elyada, Ariel Pribluda